Cargando…
Metformin in COVID-19: clinical trials are needed to prove its benefits
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741591/ https://www.ncbi.nlm.nih.gov/pubmed/34997410 http://dx.doi.org/10.1007/s11845-021-02869-9 |
| _version_ | 1784629527679336448 |
|---|---|
| author | Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad |
| author_facet | Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad |
| author_sort | Kow, Chia Siang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8741591 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87415912022-01-10 Metformin in COVID-19: clinical trials are needed to prove its benefits Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad Ir J Med Sci Letter to the Editor Springer International Publishing 2022-01-08 2022 /pmc/articles/PMC8741591/ /pubmed/34997410 http://dx.doi.org/10.1007/s11845-021-02869-9 Text en © The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad Metformin in COVID-19: clinical trials are needed to prove its benefits |
| title | Metformin in COVID-19: clinical trials are needed to prove its benefits |
| title_full | Metformin in COVID-19: clinical trials are needed to prove its benefits |
| title_fullStr | Metformin in COVID-19: clinical trials are needed to prove its benefits |
| title_full_unstemmed | Metformin in COVID-19: clinical trials are needed to prove its benefits |
| title_short | Metformin in COVID-19: clinical trials are needed to prove its benefits |
| title_sort | metformin in covid-19: clinical trials are needed to prove its benefits |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741591/ https://www.ncbi.nlm.nih.gov/pubmed/34997410 http://dx.doi.org/10.1007/s11845-021-02869-9 |
| work_keys_str_mv | AT kowchiasiang metforminincovid19clinicaltrialsareneededtoproveitsbenefits AT ramachandramdineshsangarran metforminincovid19clinicaltrialsareneededtoproveitsbenefits AT hasansyedshahzad metforminincovid19clinicaltrialsareneededtoproveitsbenefits |